Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Recs

0
Player Avatar phatchips767 (< 20) Submitted: 6/27/2012 8:06:59 PM : Outperform Start Price: $53.90 PCYC Score: +25.69

went to 300% increase for potofeille.

Report this Post Reply

Featured Broker Partners


Advertisement